Skip to content
MarketScale
‹ Back to IndustriesSciences

Just Thinking… About Bridging the Gap Between Classrooms and Real-World Scientific Research

As advancements in technology reshape how we learn, innovate, and engage with scientific research, how can we cultivate a scientific mindset in education and beyond? Today’s discussion highlights a growing emphasis on curiosity-led learning as a catalyst for systemic change in education. Curiosity plays a crucial role in learner engagement, with research showing that…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By MarketScale · Jason OsborneJust ThinkingKevin DoughertyScientific Research
Share

Key takeaways

01

As advancements in technology reshape how we learn, innovate, and engage with scientific research, how can we cultivate a scientific mindset in education and beyond?

02

Today’s discussion highlights a growing emphasis on curiosity-led learning as a catalyst for systemic change in education.

03

Curiosity plays a crucial role in learner engagement, with research showing that…

As advancements in technology reshape how we learn, innovate, and engage with scientific research, how can we cultivate a scientific mindset in education and beyond? Today’s discussion highlights a growing emphasis on curiosity-led learning as a catalyst for systemic change in education. Curiosity plays a crucial role in learner engagement, with research showing that it not only prepares the brain for learning but also significantly impacts academic achievement. So, how can we make curiosity a foundational element in classrooms and organizations?

In this episode of Just Thinking, host Kevin Dougherty is joined by Jason Osborne, the Chief Business Officer at syGlass and a multi-faceted explorer, inventor, and advocate for citizen science. Together, they explore the power of curiosity to inspire breakthroughs and discuss how we can better engineer learning systems to ignite curiosity in students, educators, and professionals alike.

Key Questions Addressed:

  • How can curiosity reshape education and scientific discovery?
  • What role does technology like VR and AR play in modern education?
  • How do we bridge the gap between K-12 education and real-world scientific research?

Key Takeaways:

  • Curiosity as a Catalyst: Osborne shares his journey from a small-town farm to becoming an inventor and White House Champion of Change.
  • Learning Engineering: Insights into how Osborne implemented systems to “engineer learning,” enabling students to contribute to real-world scientific research, including projects on neuroscience and paleontology.
  • Bridging Education and Technology: Discussion on using emerging tools like AR/VR to create immersive learning experiences and preparing students for the evolving demands of the workforce.

Jason Osborne is the Chief Business Officer at syGlass, with a career spanning biomedical science, aerospace, and education innovation. A White House Champion of Change and advocate for citizen science, Osborne has collaborated with institutions like the Howard Hughes Medical Institute, National Geographic, and the Smithsonian. His discoveries in paleontology have been chronicled by platforms like Discovery Channel and NPR, making him a pivotal figure in connecting education with cutting-edge science.

Article written by MarketScale.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Sciences expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

  • 01Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.
  • 02The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.
  • 03Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Jul 31, 2026

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

M
MarketScale

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512